{
  "abstract": "Parkinson’s disease (PD) may increase the risk of degenerative cervical myelopathy, causing overlaying myelopathic motor symptoms that can be challenging to identify. However, this diagnosis must not be missed, given the risk of profound and lasting disability and the benefit of surgical intervention. We describe a fortnight in which three patients with PD were admitted to our inpatient movement disorders service with degenerative cervical myelopathy; each highlighting a distinct learning point regarding diagnosis or management. First, that careful examination is crucial, and clinicians should always consider degenerative cervical myelopathy in a patient with PD whose mobility has dramatically reduced. Second, patients may need pharmacological suppression of cervical dyskinesias after surgery to prevent ongoing injury and to promote healing. Third, medical factors, such as B12 deficiency, with the potential to exacerbate myelopathic effects, should be corrected.",
  "authors": [
    {
      "affiliations": [
        "National Hospital for Neurology & Neurosurgery, Queen Square, University College London Hospitals NHS Foundation Trust, London, UK",
        "Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK"
      ],
      "name": "James Groves"
    },
    {
      "affiliations": [
        "National Hospital for Neurology & Neurosurgery, Queen Square, University College London Hospitals NHS Foundation Trust, London, UK",
        "Lysholm Department of Neuroradiology, National Hospital for Neurology & Neurosurgery, Queen Square, London, UK"
      ],
      "name": "Demot H Mallon"
    },
    {
      "affiliations": [
        "Victor Horsley Department of Neurosurgery, National Hospital for Neurology & Neurosurgery, London, UK"
      ],
      "name": "Anouk Borg"
    },
    {
      "affiliations": [
        "Victor Horsley Department of Neurosurgery, National Hospital for Neurology & Neurosurgery, London, UK"
      ],
      "name": "Nathalie Zaidman"
    },
    {
      "affiliations": [
        "Queen Square Movement Disorders Centre, National Hospital for Neurology & Neurosurgery, Queen Square, University College London Hospitals NHS Foundation Trust, London, UK"
      ],
      "name": "Thomas Foltynie"
    },
    {
      "affiliations": [
        "Queen Square Movement Disorders Centre, National Hospital for Neurology & Neurosurgery, Queen Square, University College London Hospitals NHS Foundation Trust, London, UK"
      ],
      "name": "Patricia Limousin"
    },
    {
      "affiliations": [
        "National Hospital for Neurology & Neurosurgery, Queen Square, University College London Hospitals NHS Foundation Trust, London, UK",
        "MRC Protein Phosphorylation & Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, UK"
      ],
      "name": "Arpan R Mehta"
    },
    {
      "affiliations": [
        "Queen Square Movement Disorders Centre, National Hospital for Neurology & Neurosurgery, Queen Square, University College London Hospitals NHS Foundation Trust, London, UK"
      ],
      "name": "L V Prasad Korlipara"
    }
  ],
  "title": "Myelopathic motor symptoms overlaying Parkinson’s disease",
  "uid": "d99b0682-4bf1-5ca3-9b36-02fc82f5e0d4"
}